AU2003209534A8 - The method of treating tuberculosis - Google Patents

The method of treating tuberculosis

Info

Publication number
AU2003209534A8
AU2003209534A8 AU2003209534A AU2003209534A AU2003209534A8 AU 2003209534 A8 AU2003209534 A8 AU 2003209534A8 AU 2003209534 A AU2003209534 A AU 2003209534A AU 2003209534 A AU2003209534 A AU 2003209534A AU 2003209534 A8 AU2003209534 A8 AU 2003209534A8
Authority
AU
Australia
Prior art keywords
treating tuberculosis
tuberculosis
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003209534A
Other versions
AU2003209534A1 (en
Inventor
Bakulesh Mafatlal Khamar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003209534A1 publication Critical patent/AU2003209534A1/en
Publication of AU2003209534A8 publication Critical patent/AU2003209534A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003209534A 2002-03-08 2003-03-04 The method of treating tuberculosis Abandoned AU2003209534A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN235/MUM/2002 2002-03-08
IN235MU2002 2002-03-08
PCT/IB2003/000802 WO2003075825A2 (en) 2002-03-08 2003-03-04 The method of treating tuberculosis

Publications (2)

Publication Number Publication Date
AU2003209534A1 AU2003209534A1 (en) 2003-09-22
AU2003209534A8 true AU2003209534A8 (en) 2003-09-22

Family

ID=27799867

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2003209534A Abandoned AU2003209534A1 (en) 2002-03-08 2003-03-04 The method of treating tuberculosis
AU2003208505A Abandoned AU2003208505A1 (en) 2002-03-08 2003-03-06 Process for preparation of a pharmaceutical composition containing acid labile compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2003208505A Abandoned AU2003208505A1 (en) 2002-03-08 2003-03-06 Process for preparation of a pharmaceutical composition containing acid labile compounds

Country Status (4)

Country Link
KR (1) KR20050008452A (en)
AU (2) AU2003209534A1 (en)
GB (1) GB2392839A (en)
WO (2) WO2003075825A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006111853A2 (en) * 2005-04-18 2006-10-26 Aurobindo Pharma Limited Stable solid dosage forms of acid labile drug
PL1948782T3 (en) * 2005-04-25 2013-01-31 Cadila Pharmaceuticals Ltd Vaccine adjuvants
WO2008062288A2 (en) * 2006-11-23 2008-05-29 Cadila Pharmaceuticals Limited Poly-tlr antagonist
WO2010122583A2 (en) 2009-04-24 2010-10-28 Rubicon Research Private Limited Oral pharmaceutical compositions of acid labile substances

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
GB9219425D0 (en) * 1992-09-14 1992-10-28 Univ London Therapeutic agent and its use
GB8918206D0 (en) * 1989-08-09 1989-09-20 Nat Inst Immunology Tuberculosis vaccine
US5232706A (en) * 1990-12-31 1993-08-03 Esteve Quimica, S.A. Oral pharmaceutical preparation containing omeprazol
SE9302395D0 (en) * 1993-07-09 1993-07-09 Ab Astra NEW PHARMACEUTICAL FORMULATION
WO2003063896A1 (en) * 2002-01-29 2003-08-07 Modi, Rajiv, Indravadan Process of preparing a pharmaceutical composition for immunity against tuberculosis in hiv positive individuals
CA2474794A1 (en) * 2002-01-29 2003-08-07 Modi, Rajiv Indravadan Method of providing prophylaxis for tuberculosis in hiv positive individuals

Also Published As

Publication number Publication date
KR20050008452A (en) 2005-01-21
AU2003208505A1 (en) 2003-09-29
AU2003209534A1 (en) 2003-09-22
AU2003208505A8 (en) 2003-09-29
WO2003077829A3 (en) 2003-12-04
WO2003077829A2 (en) 2003-09-25
WO2003075825A3 (en) 2003-11-13
GB0400094D0 (en) 2004-02-04
GB2392839A8 (en) 2004-11-18
GB2392839A (en) 2004-03-17
WO2003075825A2 (en) 2003-09-18

Similar Documents

Publication Publication Date Title
HK1249850A1 (en) Method for the treatment of multiple sclerosis
AU2003280004A8 (en) Hair treatment method
AU2003247624A8 (en) Method of treating the syndrome of lipodystrophy
IL164352A0 (en) Methods for treating tweak-related conditions
AU2003283958A8 (en) Method of treating tremors
IL164219A0 (en) Method for treating and preventing hyparathyroidism
GB0129976D0 (en) Treatment method
EP1577280A4 (en) Method of deuterization
AU2003258551A8 (en) Method for the treatment of fiber material
EP1491091A4 (en) Insect-proofing means and method of insect-proofing
GB0120147D0 (en) Treatment method
AU2003209534A8 (en) The method of treating tuberculosis
GB0208897D0 (en) New method of treatment
GB0221712D0 (en) Methods of treatment
GB0215867D0 (en) Novel method and compounds
AU2003213109A8 (en) Method for treating cellulite
GB0213198D0 (en) Method of treatment
GB0222736D0 (en) Method of authentication
GB0126253D0 (en) Treatment method
GB0207091D0 (en) Method of treatment
GB0221582D0 (en) Method of treatment
GB0201281D0 (en) Method of treatment
GB0226275D0 (en) Method of treatment
GB0206699D0 (en) Method of treatment
GB0215583D0 (en) Method of treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase